Sage Journals: Discover world-class research

Free access

Review article

First published 2014-10

Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes

Bernard Peene, Katrien Benhalima

Therapeutic Advances in Endocrinology and Metabolism

Free access

Brief report

First published 2018-3

Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure

Tsuneo Takenaka, Yoichi Ohno, Hiromichi Suzuki

Diabetes & Vascular Disease Research

Free access

Brief report

First published 2017-5

Sodium–glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy

Tsuneo Takenaka, Miyako Kishimoto, Mari Ohta [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2022-05-17

Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes

Serena Low, Kiat Sern Goh, Tze Pin Ng [...]

Journal of Alzheimer’s Disease

Open access

Review article

First published 2016-6

Benefits/Risks of Sodium–Glucose Co-Transporter 2 Inhibitor Canagliflozin in Women for the Treatment of Type 2 Diabetes

Pamela Kushner

Women's Health

Open access

Review article

First published 2024

Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review

Afif Nakhleh, Jomana Mazareeb, Said Darawshi [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Retricted access

Research article

First published 2011-12

Safety,Pharmacokinetic,and Pharmacodynamic Profiles of Ipragliflozin (ASP1941),a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2,in Patients with Type 2 Diabetes Mellitus

Sherwyn L. Schwartz, Bola Akinlade, Sally Klasen [...]

Diabetes Technology & Therapeutics

Free access

Research article

First published 2018-1

Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis

Tracey Gaspari, Iressa Spizzo, HongBin Liu [...]

Diabetes & Vascular Disease Research

Open access

Research article

First published 2022

‘A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service’

Padeepa Perera, Ronan O’Donnabhain, Timothy Fazio [...]

Clinical Medicine Insights: Cardiology

Retricted access

Review article

First published 2019-12

Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data

Kajal Patel, Antonia Carbone

Annals of Pharmacotherapy

Search results